Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-15

FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Aurolife Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for HYDROCODONE BITARTRATE AND IBUPROFEN from Aurolife Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocodone Bitartrate and Ibuprofen (Hydrocodone Bitartrate and Ibuprofen)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND IBUPROFEN (HYDROCODONE BITARTRATE AND IBUPROFEN)